Diamond Biotechnology , Ltd Profit Margin

Diamond Biotechnology , Ltd posts a profit margin of -1.29% as of June 2026. That compares with 9.05% in the prior-year period — down 114.3% year over year. That is below the sector sector average of 13.2%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Diamond Biotechnology , Ltd's profit margin was 9.05%. The latest reading is -1.29% — a 114.3% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.2% is typical. Diamond Biotechnology , Ltd's -1.29% is lower that level. That is roughly 109.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Diamond Biotechnology , Ltd's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -1.29% as of June 2026; use YoY and peer views to separate noise from signal.

Context for 6815.TWO's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.2%), and (3) consistency with growth and profitability. This page covers the first two; Diamond Biotechnology , Ltd's other metric pages and overview cover the third.